Scarica l'app Stockscreener
3.41
0.59%
0.02
Dopo l'orario di chiusura:
3.42
0.010
+0.29%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.39
Aprire:
$3.42
Volume 24 ore:
2.42M
Relative Volume:
0.97
Capitalizzazione di mercato:
$369.04M
Reddito:
-
Utile/perdita netta:
$-258.08M
Rapporto P/E:
-1.24
EPS:
-2.75
Flusso di cassa netto:
$-202.32M
1 W Prestazione:
-2.57%
1M Prestazione:
+11.80%
6M Prestazione:
+16.38%
1 anno Prestazione:
-71.63%
Intervallo 1D:
$3.36
$3.50
Intervallo di 1 settimana:
$3.35
$3.65
Portata 52W:
$2.19
$13.35
Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile
Nome
Rocket Pharmaceuticals Inc
Settore
Industria
Telefono
646-440-9100
Indirizzo
350 FIFTH AVENUE, NEW YORK, NY
Confronta RCKT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RCKT
Rocket Pharmaceuticals Inc
|
3.41 | 366.87M | 0 | -258.08M | -202.32M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-18 | Downgrade | JP Morgan | Neutral → Underweight |
| 2025-08-20 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-07-25 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-05-30 | Downgrade | Evercore ISI | Outperform → In-line |
| 2025-05-28 | Downgrade | Goldman | Neutral → Sell |
| 2025-05-28 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-05-28 | Downgrade | Jefferies | Buy → Hold |
| 2025-05-28 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-05-28 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-27 | Downgrade | Needham | Buy → Hold |
| 2025-05-27 | Downgrade | TD Cowen | Buy → Hold |
| 2025-03-12 | Iniziato | BMO Capital Markets | Outperform |
| 2024-12-30 | Iniziato | Wedbush | Outperform |
| 2024-12-18 | Iniziato | Jefferies | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-04-02 | Iniziato | Goldman | Neutral |
| 2023-10-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-02-01 | Iniziato | Morgan Stanley | Overweight |
| 2022-11-08 | Iniziato | Canaccord Genuity | Buy |
| 2022-11-01 | Iniziato | BTIG Research | Buy |
| 2022-07-08 | Iniziato | Raymond James | Outperform |
| 2021-10-20 | Ripresa | Cowen | Outperform |
| 2021-03-02 | Iniziato | Stifel | Buy |
| 2021-02-18 | Iniziato | Needham | Buy |
| 2020-12-16 | Iniziato | UBS | Buy |
| 2020-12-08 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-07-02 | Iniziato | JP Morgan | Overweight |
| 2020-06-25 | Ripresa | BofA/Merrill | Buy |
| 2020-06-01 | Ripresa | Oppenheimer | Outperform |
| 2019-11-06 | Iniziato | Chardan Capital Markets | Buy |
| 2019-09-26 | Iniziato | Piper Jaffray | Overweight |
| 2019-04-23 | Iniziato | Robert W. Baird | Outperform |
| 2019-03-15 | Iniziato | BofA/Merrill | Buy |
| 2019-02-05 | Iniziato | Oppenheimer | Outperform |
| 2018-09-13 | Iniziato | Ladenburg Thalmann | Buy |
| 2018-07-10 | Iniziato | William Blair | Outperform |
Mostra tutto
Rocket Pharmaceuticals Inc Borsa (RCKT) Ultime notizie
Rocket Pharmaceuticals (RCKT) Stock Target Reduced Following Q3 2025 Update on Cash Position - Yahoo Finance
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Maverick Capital Ltd. Has $20.49 Million Stock Position in Rocket Pharmaceuticals, Inc. $RCKT - MarketBeat
Rocket Pharmaceuticals (NASDAQ:RCKT) Share Price Passes Below Fifty Day Moving AverageHere's Why - MarketBeat
Rocket Pharmaceuticals (NASDAQ:RCKT) Nasdaq Index Drives Rare-Disease Research - Kalkine Media
What analysts say about Rocket Pharmaceuticals Inc stockConsumer Goods Stocks & Small Entry Cost Investments - earlytimes.in
Rocket Pharmaceuticals, Inc. (RCKT) Gene Therapy Trial Paused Following Patient Death - MSN
Forecast Cut: Can Rocket Pharmaceuticals Inc. Equity Warrant stock maintain growth trajectoryPortfolio Gains Report & Free Real-Time Volume Trigger Notifications - moha.gov.vn
Is Rocket Pharmaceuticals Inc. (9IP1) stock undervalued after correctionJobs Report & High Accuracy Trade Alerts - Newser
What Wall Street predicts for Rocket Pharmaceuticals Inc. Equity Warrant stock price - Newser
Rocket Pharmaceuticals heads to Lisbon for Cardio Genomics Meeting - Traders Union
Is Rocket Pharmaceuticals Inc. (9IP1) stock among top earnings playsWeekly Profit Report & Expert Approved Trade Ideas - Newser
Will Rocket Pharmaceuticals Inc. (9IP1) stock test record highs in 20252025 Big Picture & Growth Oriented Trade Recommendations - Newser
Is Rocket Pharmaceuticals Inc. Equity Warrant stock near bottom after declineWeekly Stock Analysis & Capital Efficiency Focused Ideas - Newser
Is Rocket Pharmaceuticals Inc. stock positioned well for digital economyPortfolio Return Summary & Reliable Volume Spike Alerts - Newser
How Rocket Pharmaceuticals Inc. (9IP1) stock trades pre earnings2025 Volatility Report & Free Expert Verified Stock Movement Alerts - Newser
Is Rocket Pharmaceuticals Inc. (9IP1) stock a buy on weaknessMarket Rally & Daily Stock Trend Watchlist - Newser
Published on: 2025-12-02 03:22:04 - Newser
Published on: 2025-12-02 19:13:04 - BỘ NỘI VỤ
Class Action Alert: Levi & Korsinsky Reminds Rocket (RCKT) Investors of August 11, 2025 Deadline - The National Law Review
Securities Class Action Lawsuit Filed Against Rocket Pharmaceutic - The National Law Review
Rocket Pharmaceuticals Inc (RCKTW) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
How Rocket Pharmaceuticals Inc. Equity Warrant stock performs in weak economyWeekly Trend Recap & Daily Profit Focused Screening - BỘ NỘI VỤ
What is the fair value of Rocket Pharmaceuticals Inc. stock nowInflation Watch & Smart Allocation Stock Reports - moha.gov.vn
Will Rocket Pharmaceuticals Inc. stock deliver consistent dividendsTrade Ideas & High Accuracy Swing Trade Signals - BỘ NỘI VỤ
DEADLINE NEXT WEEK: Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit (PR Newswire) - Aktiellt
How buybacks impact Rocket Pharmaceuticals Inc. stock valuePortfolio Gains Report & Weekly Hot Stock Watchlists - BỘ NỘI VỤ
Aug Big Picture: How buybacks impact Rocket Pharmaceuticals Inc. stock valueEarnings Overview Summary & Real-Time Volume Analysis Alerts - BỘ NỘI VỤ
Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference - Business Wire
Skyline Ventures India Limited Moves Into Bullish Territory Based on MACDIndustrial Stocks Review & Rapid Wealth Accumulation - earlytimes.in
Why Rocket Pharmaceuticals Inc. Equity Warrant stock could be next big winner2025 Risk Factors & AI Powered Market Entry Strategies - newser.com
Can Rocket Pharmaceuticals Inc. (9IP1) stock sustain revenue momentum2025 Top Decliners & Intraday High Probability Alerts - newser.com
How Rocket Pharmaceuticals Inc. (9IP1) stock compares with top peersTrade Signal Summary & Technical Pattern Based Signals - newser.com
Is Rocket Pharmaceuticals Inc. stock entering bullish territoryWeekly Trade Summary & AI Enhanced Trade Execution Alerts - newser.com
How Rocket Pharmaceuticals Inc. (9IP1) stock correlates with oil marketsPrice Action & AI Driven Stock Movement Reports - newser.com
Can Rocket Pharmaceuticals Inc. (9IP1) stock retain market dominance2025 Market Overview & Weekly Market Pulse Updates - newser.com
Amitell Capital Pte Ltd Acquires New Holdings in Rocket Pharmaceuticals, Inc. $RCKT - MarketBeat
Applying big data sentiment scoring on Rocket Pharmaceuticals Inc. Equity WarrantShare Buyback & AI Powered Market Entry Ideas - newser.com
Using R and stats models for Rocket Pharmaceuticals Inc. forecastingQuarterly Market Summary & Daily Stock Trend Watchlist - newser.com
Rocket Pharmaceuticals CEO Sells Shares - TradingView
CEO Shah Sells 6,276 ($18.7K) Of Rocket Pharmaceuticals Inc [RCKT] - TradingView
[Form 4] ROCKET PHARMACEUTICALS, INC. Insider Trading Activity - Stock Titan
Rocket Pharmaceuticals, Inc.Common Stock (Nasdaq:RCKT) Stock Quote - Markets Financial Content
How Rocket Pharmaceuticals Inc. stock reacts to inflationary pressuresWall Street Watch & Safe Capital Growth Tips - newser.com
How Rocket Pharmaceuticals Inc. (9IP1) stock trades after rate cutsJuly 2025 Sentiment & Risk Controlled Stock Pick Alerts - newser.com
Published on: 2025-11-20 03:46:18 - newser.com
Is Rocket Pharmaceuticals Inc. stock oversold or undervalued2025 Risk Factors & Intraday High Probability Alerts - newser.com
RCKT General Counsel reports 1,646-share stock sale on Form 4 - Stock Titan
Using data models to predict Rocket Pharmaceuticals Inc. Equity Warrant stock movementJuly 2025 Chart Watch & Free High Return Stock Watch Alerts - newser.com
What dividend safety rating applies to Rocket Pharmaceuticals Inc. (9IP1) stock2025 AllTime Highs & Technical Analysis for Trade Confirmation - newser.com
Why Rocket Pharmaceuticals Inc. (9IP1) stock could be next leader2025 Short Interest & Low Drawdown Investment Strategies - newser.com
Rocket Pharmaceuticals Inc Azioni (RCKT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):